Research Radboud technology centers Radboud Biobank News Pilot Broad Consent at the Gate
25 February 2020

The Blue Diamond Gallery

In line with the NFU initiative “Broad Consent at the Gate” (Breed Consent aan de Poort), the Radboud Biobank is currently conducting a feasibility study examining consent procedures for the use of residual material for scientific research. Residual material encompasses biomaterials leftover from standard clinical procedures, clinical imaging and medical data. The specific aim of this study is to evaluate the impact of implementing an active consent procedure (i.e. opt-in consent, which requires explicit consent) in place of the passive consent procedure currently used in the Radboudumc (i.e. opt-out consent, which requires explicit objection). Importantly, this study does not override the consent status of previously established research studies.
As of January 13, 2020, each new patient registering for the first time at the Radboudumc is actively asked for consent to use his/her residual biomaterial, clinical imaging and medical data for scientific research. To date, there has been no major organizational obstacles in the implementation of this new consent procedure. However, its impact on available material and data is still under evaluation. In addition to quantitative analyses, qualitative research exploring underlying motivations of patients who consent or do not consent to the use of their material and data will also be performed. This feasibility study will be further expanded to assess the impact of the new consent procedure on vulnerable patient groups, i.e. children (<16 years old), acute care patients, and incapacitated patients.   
For further information, please visit our website, “Use of medical data and leftover biomaterial”  (available in Dutch only), or contact Dr. Jennifer Lutomski, project leader, at Jennifer.Lutomski@radboudumc.nl.
 
  • Want to know more about these subjects? Click on the buttons below for more news.

    Radboud Biobank

Related news items


Biobanking: the power of collecting

26 May 2020

Urine, cerebrospinal fluid, blood. Everything is stored in Dutch biobanks. Collecting this takes a lot of time and money. Is it worth that? What does it yield?

read more

Costs for internal researchers in case of request for samples

26 May 2020

As of January 1, 2020, internal researchers who request samples from the Radboud Biobank will only be charged for the number of samples received.

read more

New sub-biobanks

26 May 2020

The Radboud Biobank has added one new sub-biobank to the collection: HEMLYM.

read more

Biobank OPMD

25 February 2020

In oculopharyngeal muscular dystrophy (OPMD), muscle strength slowly decreases due to a breakdown of muscle cells. The Biobank OPMD contains clinical data and residual biomaterial.

read more

Biobank BVO

25 February 2020

The Biobank BVO contains left-over cytological material from the cervical screening program. The ambition of the BVO Biobank is to make this residual material available for scientific research.

read more

BBMRI-NL series on sustainable biobanking

25 February 2020

BBMRI-NL has made a series on sustainable biobanking, combining current knowledge from literature, workshops, and focus groups.

read more